During the past decade, Aspirus Cancer Care - Wisconsin Rapids conducted 84 clinical trials. In the 10-year time frame, 84 clinical trials started and 64 clinical trials were completed, i.e. on average, 76.2% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 42 clinical trials were completed. i.e. 116.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aspirus Cancer Care - Wisconsin Rapids" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "NRG Oncology" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aspirus Cancer Care - Wisconsin Rapids" #1 collaborator was "National Cancer Institute (NCI)" with 79 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Canadian Cancer Trials Group" with 5 trials as a collaborator. Other collaborators include 30 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Aspirus Cancer Care - Wisconsin Rapids" are "Breast Cancer" (9 trials), "Invasive Breast Carcinoma" (8 trials), "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Prostate Cancer" (7 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials). Many other conditions were trialed in "Aspirus Cancer Care - Wisconsin Rapids" in a lesser frequency.

Most popular intervention types in "Aspirus Cancer Care - Wisconsin Rapids" are "Drug" (116 trials), "Other" (87 trials), "Biological" (56 trials), "Radiation" (34 trials) and "Procedure" (29 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (43 trials), "Quality-of-Life Assessment" (40 trials), "Questionnaire Administration" (20 trials), "Biospecimen Collection" (17 trials) and "Cisplatin" (16 trials). Other intervention names were less common.

The vast majority of trials in "Aspirus Cancer Care - Wisconsin Rapids" are 111 trials for "All" genders, 15 trials for "Male" genders and 13 trials for "Female" genders.

Currently, there are NaN active trials in "Aspirus Cancer Care - Wisconsin Rapids". undefined are not yet recruiting, 34 are recruiting, 65 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Aspirus Cancer Care - Wisconsin Rapids, 3 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Aspirus Cancer Care - Wisconsin Rapids, 2 "Phase 1" clinical trials were conducted, 56 "Phase 2" clinical trials and 91 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".